Thyrocare Technologies files DRHP with SEBI

Diagnostics Company Thyrocare Technologies has filed draft red herring prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) of 10.7 million shares. The company is planning to raise $85 million to $100 million through a stock market listing.

Thyrocare is planning to list on both the BSE and NSE exchanges. JM Financial, Edelweiss Financial, ICICI Securities are lead managers for the issue.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in more than 2000 cities / towns in India and internationally. Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia.